DOR/ISL Maintains HIV Viral Suppression at 96 Weeks: Study Results
February 24, 2026 | ARCHYDE
DOR/ISL Maintains HIV Viral Suppression at 96 Weeks: Study Results...
Host immune responses to viral coinfection with Human papillomavirus (HPV)16/18 SARS-CoV-2 and HIV: an ex-vivo study
February 24, 2026 | Springer
Abstract
Objective
In an ex-vivo study, immune responses to HPV antigens among women age...
Study: Pre-Exposure Prophylaxis Significantly Under-Prescribed to Prevent HIV in Eligible Patients
February 24, 2026 | Pharmacy Times
Primary care physicians, particularly in family medicine, offer PrEP at a significantly lo...
Italian Conference on AIDS and Antiviral Research National Congress
February 24, 2026 | PubsHub Journals & Congresses
Italian Conference on AIDS and Antiviral Research National Congress...
Researchers probe two cases of infection after anti-HIV shot
February 24, 2026 | The Star, Kenya
Experts warn Lenacapavir is not a substitute for comprehensive HIV prevention strategies....
Regularized regression models for accurate prediction of HIV progression in ART patients: a comparative study
February 23, 2026 | Nature
Abstract
This study compared four regularized regression techniques Ridge, Least Absolute...
CROI 2026: Funding Cuts, Censorship & the Future of HIV Research
February 23, 2026 | Archy Newsy
ViiV Healthcare Advances Ultra Long-Acting HIV Treatment and Prevention at CROI 2026
New ...